Literature DB >> 10325268

Hysteroscopic treatment of severe Asherman's syndrome and subsequent fertility.

S Capella-Allouc1, F Morsad, C Rongières-Bertrand, S Taylor, H Fernandez.   

Abstract

In a retrospective case report series, we evaluated the efficacy of hysteroscopic adhesiolysis in patients with severe Asherman's syndrome. In 31 patients with permanent severe adhesions, hysteroscopic treatment was performed. In all patients, uterine cavity with at least one free ostial area was restored after one (n = 16), two (n = 7), three (n = 7), and four (n = 1) surgical procedures. All previously amenorrhoeic patients (n = 16) had resumption of menses. Twenty-eight patients were followed-up with a mean time of 31 months (range 2-84). Fifteen pregnancies were obtained in 12 patients and the outcomes were the following: two first trimester missed abortions, three second trimester fetal losses, one second trimester termination of pregnancy for multiple fetal abnormalities and nine live births in nine different patients. Pregnancy rate after treatment was 12/28 (42.8%) and live birth rate was 9/28 (32.1%). In patients </=35 years, 10 out of 16 conceived (62.5%) versus two out of 12 (16.6%) in patients >35 years (P = 0. 01). Three patients were lost to follow-up and their results omitted. In nine patients with live births, one Caesarean hysterectomy for placenta accreta and one hypogastric arteries ligation for severe haemorrhage and placenta accreta were performed. Hysteroscopic treatment of severe Asherman's syndrome appeared to be effective for the reconstruction of a functional uterine cavity with a 42.8% pregnancy rate. However, these pregnancies were at risk for haemorrhage with abnormal placentation.

Entities:  

Mesh:

Year:  1999        PMID: 10325268     DOI: 10.1093/humrep/14.5.1230

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  23 in total

1.  Extended estrogen administration for women with thin endometrium in frozen-thawed in-vitro fertilization programs.

Authors:  Mei-Jou Chen; Jehn-Hsiahn Yang; Fu-Hsiang Peng; Shee-Uan Chen; Hong-Nerng Ho; Yu-Shih Yang
Journal:  J Assist Reprod Genet       Date:  2006 Jul-Aug       Impact factor: 3.412

2.  Hyaluronic Acid Hydrogel Integrated with Mesenchymal Stem Cell-Secretome to Treat Endometrial Injury in a Rat Model of Asherman's Syndrome.

Authors:  Feiran Liu; Shiqi Hu; Hua Yang; Zhenhua Li; Ke Huang; Teng Su; Shaowei Wang; Ke Cheng
Journal:  Adv Healthc Mater       Date:  2019-05-30       Impact factor: 9.933

3.  Effects of endometrial stem cell transplantation combined with estrogen in the repair of endometrial injury.

Authors:  Xinrong Wang; Hongchu Bao; Xuemei Liu; Chengde Wang; Cuifang Hao
Journal:  Oncol Lett       Date:  2018-05-11       Impact factor: 2.967

4.  Logistic regression analyses of factors affecting fertility of intrauterine adhesions patients.

Authors:  Xingping Zhao; Yunzhi Liu; Aiqian Zhang; Bingsi Gao; Qing Feng; Huan Huang; Xiuting Zhu; Xin Sun; Dabao Xu
Journal:  Ann Transl Med       Date:  2020-02

5.  The Overexpression of TGF-β and CCN2 in Intrauterine Adhesions Involves the NF-κB Signaling Pathway.

Authors:  Xiang Xue; Qing Chen; Gang Zhao; Jin-Yan Zhao; Zhao Duan; Peng-Sheng Zheng
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

Review 6.  Efficacy of intrauterine device in the treatment of intrauterine adhesions.

Authors:  Umme Salma; Min Xue; Ali Sheikh Md Sayed; Dabao Xu
Journal:  Biomed Res Int       Date:  2014-09-01       Impact factor: 3.411

Review 7.  The management of Asherman syndrome: a review of literature.

Authors:  Alessandro Conforti; Carlo Alviggi; Antonio Mollo; Giuseppe De Placido; Adam Magos
Journal:  Reprod Biol Endocrinol       Date:  2013-12-27       Impact factor: 5.211

8.  Autologous stem cell transplantation in refractory Asherman's syndrome: A novel cell based therapy.

Authors:  Neeta Singh; Sujata Mohanty; Tulika Seth; Meenakshi Shankar; Sruthi Bhaskaran; Sona Dharmendra
Journal:  J Hum Reprod Sci       Date:  2014-04

9.  Bone Marrow-Derived Stem Cell (BMDSC) transplantation improves fertility in a murine model of Asherman's syndrome.

Authors:  Feryal Alawadhi; Hongling Du; Hakan Cakmak; Hugh S Taylor
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

10.  Patient-reported menstrual and obstetric outcomes following hysteroscopic adhesiolysis for Asherman syndrome.

Authors:  Blanca Morales; Peter Movilla; Joyce Wang; Jennifer Wang; Alexandria Williams; Tammy Chen; Himabindu Reddy; Jovana Tavcar; Megan Loring; Stephanie Morris; Keith Isaacson
Journal:  F S Rep       Date:  2021-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.